Inhibition of angiogenesis by a new isocoumarin, NM-3.
T
T
Nakashima
S
S
Hirano
N
N
Agata
H
H
Kumagai
K
K
Isshiki
T
T
Yoshioka
M
M
Ishizuka
K
K
Maeda
T
T
Takeuchi
D000818:Animals; D000925:Anticoagulants / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D003374:Coumarins / Q000302:isolation & purification* / Q000494:pharmacology / Q000627:therapeutic use; D015194:Diffusion Chambers, Culture; D004305:Dose-Response Relationship, Drug; D005260:Female; D049934:Isocoumarins; D051379:Mice; D008813:Mice, Inbred ICR; D009389:Neovascularization, Pathologic / Q000188:drug therapy*; D012510:Sarcoma 180 / Q000473:pathology; D014407:Tumor Cells, Cultured
D000925:Anticoagulants; D000970:Antineoplastic Agents; D003374:Coumarins; D049934:Isocoumarins; C453300:isocoumarin NM-3; C066806:cytogenin